News & Events
Dr. Ashok Srivastava, MD, Ph.D., MBA
Medical Oncologist and Hematologist,
CAR-T Cell Therapy and Oncolytic Virus Therapy of Metastatic Breast and Brain Cancers
Attends and Chair the sessions- The 4th Congress of Biopharma Industry Development 2025, Shanghai, China
Dr. Ashok Srivastava will attend the Cancer and Oncology Research, May 30-31, 2024 Rome, Italy as Invited Speaker and he will Chair the Sessions.
Year 2020
Dr. Ashok Srivastava, MD, Ph.D., MBA and Dr. Pallavi Dhillon, Phar,D, Ph.D.: has been invited as guest speaker at Global Summit on Oncology and Breast Cancer, on May 04-05, 2020 Vienna, Austria: https://www.longdom.com/oncology-congress
Dr. Ashok Srivastava, MD, Ph.D., MBA has been appointed as invemest firm as Pharma Capital Partners, January 2020: www.pharmacapitalpartners.com
Year 2019
Dr. Ashok Srivastava, MD, Ph.D., MBA has been appointed and Board Member of Cailidi Biotherapeutics, San Diego, California, USA, 2019: https://www.prnewswire.com/news-releases/calidi-biotherapeutics-announces-the-appointment-of-seasoned-biotech-executive-dr-ashok-srivastava-to-their-scientific-advisory-board-300858945.html
Dr. Ashok Srivastava, MD, Ph.D., MBA, CEO and CMO of Transtherapeutic was interviwed by https://www.usatvnews.org/
Transtherapeutic A Best Breast Cancer Contract Research Organization in USA: By USA TV NEWS, February 25, 2019: http://www.usatvnews.org/clinfomatrix-best-breast-cancer-contract-research-organization-usa/
Dr. Ashok Srivastava, MD, Ph.D., MBA , CEO and CMO of Transtherapeutic was interviwed by : Transtherapeutic – Best Consulting Company For Oncology Drug Launch, USA TV NEWS, January 15, 2019: http://www.usatvnews.org/clinfomatrix-best-consulting-company-oncology-drug-launch/
Dr. Ashok Srivastava, MD, Ph.D., MBA , CEO and CMO of Transtherapeutic was invited as International Honorarary Cahirman of Annula World Cancer Congress-May 15-17, 2019, Osaka, Japan, http://www.bitcongress.com/cancer2019/
Year 2018
Transtherapeutic: Dr. Srivastava, is Key Note speaker at International Conference on hematology & Oncology, 23-25, August 2018, London, UK: http://hematology.alliedacademies.com/
Transtherapeutic: Dr. Srivastava, is Key Note speaker at International Conference on Blood Disorders and Haematology, 20-21, September, San Francisco, CA: https://www.clytoaccess.com/international-conference-blood-disorders-and-haematology
Cure Pharmaceuticals, INC: Dr. Srivastava, is Key Note speaker at International Conference on Blood Disorders and Haematology, 20-21, September, San Francisco, CA: https://www.clytoaccess.com/international-conference-blood-disorders-and-haematology
- Dr. Ashok Srivastava presents at: http://www.pveurope.com/speaker.php 24-25 May 2017, London, UK, London
- Dr. Ashok srivastava attends American Society of Clinical Oncology (ASCO), https://www.asco.org June 2-6, 2017, Chicago, USA
- Dr. Ashok Srivastava presents as Key Note Speaker; Challenges in Breast Cancer Treatment and Drug Safety. Key Note Speaker, at 8th Global Drug safety Summit, Global Pharmacovigilance 2017, http://globalpharmacovigilance.pharmaceuticalconferences.com/scientific-program ; July 6-7, Kaula Lumpur, Malaysia
